Industry Spotlight

Support for innovation - real or rhetoric?

16 February 2017 via Biotech Dispatch: The Turnbull governments approach to innovation will be tested in the months ahead. Is it real or just rhetoric? Malcolm Turnbull replaced Tony Abbott as prime minister in 2015 and actively promoted innovation as fundamental to... | READ MORE

Government announces appointment of cannabis advisory council

16 February 2017 via Biotech Dispatch: Health minister Greg Hunt has announced the appointment of members to the Australian Advisory Council on the Medicinal Use of Cannabis - which will provide expert advice to government. Government is working towards enabling the... | READ MORE

CSL therapy shows potential diabetic kidney disease

14 February 2017 via Biotech Dispatch: An international team of scientists working in collaboration with CSL has successfully prevented the progression of Diabetic Kidney Disease (DKD) in laboratory studies of type 2 diabetes. The findings, which have been published... | READ MORE

Cook Medical Australia invests in new Australian commercialisation centre

14 February 2017 via Biotech Dispatch: Medical device manufacturer Cook Medical Australia has officially opened a new commercialisation and development centre in Brisbane. Cook Medical Australia is committing $4 million to establishing the Asia Pacific Commercialisa... | READ MORE

Bionomics receives first milestone payment

9 February 2017 via Biotech Dispatch: Good news for Adelaide-based biotechnology company Bionomics with completion of the first milestone in its ongoing collaboration with MSD. The collaboration, which was announced in June 2014, covers the development of novel cand... | READ MORE

AusBiotech backs TGA bill to cut red tape

9 February 2017 via Biotech Dispatch: AusBiotech backs regulatory reform and the reduction in the burden of red tape, expressing support for The Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2017, which is currently before the federal parliament. The Bill w... | READ MORE

Applications open for GCF priming grants

7 February 2017 via Biotech Dispatch: Industry and innovation minister Senator Arthur Sinodinos has officially opened applications for the second round of the priming grants component of the Global Connections Fund (GCF). The grants are designed to help Australian s... | READ MORE

Immuron announces first patient enrolled in new phase II trial

7 February 2017 via Biotech Dispatch: Immuron (ASX:IMC), a biopharmaceutical company focused on oral immunotherapy utilising polyclonal antibody products to target inflammatory-mediated diseases, has announced that Emory University has enrolled its first patient in i... | READ MORE

Cynata reports positive data from early study

2 February 2017 via Biotech Dispatch: Stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), says it has received very encouraging initial data from a proof of concept study of its Cymerus mesenchymal stem cells (MSCs) in an experimental rat mode... | READ MORE

Ethics approval for OncoSil pancreatic cancer study

2 February 2017 via Biotech Dispatch: Medical device company OncoSil Medical (ASX:OSL), which is focused on localised treatments for patients with pancreatic and liver cancer, has been granted Ethics Approval by Monash Health for its OncoPaC global clinical study pro... | READ MORE

Previous page | Next page
Jump to page